nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—PIK3R2—female gonad—testicular cancer	0.0235	0.0996	CbGeAlD
Isoprenaline—PIK3R3—gonad—testicular cancer	0.0196	0.0831	CbGeAlD
Isoprenaline—ADRBK1—embryo—testicular cancer	0.0171	0.0724	CbGeAlD
Isoprenaline—MAPK1—embryo—testicular cancer	0.0168	0.0713	CbGeAlD
Isoprenaline—PIK3R3—female gonad—testicular cancer	0.0159	0.0676	CbGeAlD
Isoprenaline—PIK3R3—testis—testicular cancer	0.0141	0.0599	CbGeAlD
Isoprenaline—PIK3R1—female gonad—testicular cancer	0.0136	0.0577	CbGeAlD
Isoprenaline—PIK3R1—testis—testicular cancer	0.0121	0.0512	CbGeAlD
Isoprenaline—ADRBK1—gonad—testicular cancer	0.0116	0.0491	CbGeAlD
Isoprenaline—MAPK1—gonad—testicular cancer	0.0114	0.0484	CbGeAlD
Isoprenaline—PIK3R3—lymph node—testicular cancer	0.0102	0.0434	CbGeAlD
Isoprenaline—ADRB3—female gonad—testicular cancer	0.00963	0.0408	CbGeAlD
Isoprenaline—ADRBK1—female gonad—testicular cancer	0.00941	0.0399	CbGeAlD
Isoprenaline—MAPK1—female gonad—testicular cancer	0.00927	0.0393	CbGeAlD
Isoprenaline—PIK3R1—lymph node—testicular cancer	0.00874	0.0371	CbGeAlD
Isoprenaline—ADRBK1—testis—testicular cancer	0.00835	0.0354	CbGeAlD
Isoprenaline—MAPK1—testis—testicular cancer	0.00823	0.0349	CbGeAlD
Isoprenaline—Tachyarrhythmia—Epirubicin—testicular cancer	0.00673	0.0588	CcSEcCtD
Isoprenaline—Tachyarrhythmia—Doxorubicin—testicular cancer	0.00623	0.0544	CcSEcCtD
Isoprenaline—ADRBK1—lymph node—testicular cancer	0.00605	0.0257	CbGeAlD
Isoprenaline—MAPK1—lymph node—testicular cancer	0.00596	0.0253	CbGeAlD
Isoprenaline—Ventricular arrhythmia—Ifosfamide—testicular cancer	0.00375	0.0328	CcSEcCtD
Isoprenaline—CYP1A1—female gonad—testicular cancer	0.00254	0.0108	CbGeAlD
Isoprenaline—Pulmonary oedema—Ifosfamide—testicular cancer	0.00247	0.0216	CcSEcCtD
Isoprenaline—Angina pectoris—Vinblastine—testicular cancer	0.00235	0.0205	CcSEcCtD
Isoprenaline—Bronchospasm—Bleomycin—testicular cancer	0.00201	0.0175	CcSEcCtD
Isoprenaline—Cardiac arrest—Ifosfamide—testicular cancer	0.00192	0.0167	CcSEcCtD
Isoprenaline—Tremor—Chlorambucil—testicular cancer	0.00172	0.015	CcSEcCtD
Isoprenaline—Bronchospasm—Ifosfamide—testicular cancer	0.00171	0.015	CcSEcCtD
Isoprenaline—Angina pectoris—Ifosfamide—testicular cancer	0.0017	0.0148	CcSEcCtD
Isoprenaline—Ventricular arrhythmia—Epirubicin—testicular cancer	0.00166	0.0145	CcSEcCtD
Isoprenaline—CYP1A1—lymph node—testicular cancer	0.00163	0.00693	CbGeAlD
Isoprenaline—Convulsion—Chlorambucil—testicular cancer	0.00159	0.0139	CcSEcCtD
Isoprenaline—Ventricular arrhythmia—Doxorubicin—testicular cancer	0.00154	0.0134	CcSEcCtD
Isoprenaline—Flushing—Bleomycin—testicular cancer	0.00151	0.0132	CcSEcCtD
Isoprenaline—Cardiac arrest—Etoposide—testicular cancer	0.00151	0.0132	CcSEcCtD
Isoprenaline—Vertigo—Vinblastine—testicular cancer	0.00151	0.0132	CcSEcCtD
Isoprenaline—Convulsion—Vinblastine—testicular cancer	0.00146	0.0127	CcSEcCtD
Isoprenaline—Hypertension—Vinblastine—testicular cancer	0.00145	0.0127	CcSEcCtD
Isoprenaline—Flushing—Dactinomycin—testicular cancer	0.00141	0.0123	CcSEcCtD
Isoprenaline—Bronchospasm—Etoposide—testicular cancer	0.00135	0.0118	CcSEcCtD
Isoprenaline—Flushing—Ifosfamide—testicular cancer	0.00129	0.0113	CcSEcCtD
Isoprenaline—Arrhythmia—Ifosfamide—testicular cancer	0.00125	0.0109	CcSEcCtD
Isoprenaline—Pulmonary oedema—Methotrexate—testicular cancer	0.00117	0.0102	CcSEcCtD
Isoprenaline—Vision blurred—Ifosfamide—testicular cancer	0.00114	0.00999	CcSEcCtD
Isoprenaline—Flushing—Cisplatin—testicular cancer	0.00112	0.00974	CcSEcCtD
Isoprenaline—Pulmonary oedema—Epirubicin—testicular cancer	0.00109	0.00955	CcSEcCtD
Isoprenaline—Vertigo—Ifosfamide—testicular cancer	0.00109	0.00952	CcSEcCtD
Isoprenaline—Hypotension—Bleomycin—testicular cancer	0.00108	0.00946	CcSEcCtD
Isoprenaline—Asthenia—Chlorambucil—testicular cancer	0.00107	0.00938	CcSEcCtD
Isoprenaline—Arrhythmia—Cisplatin—testicular cancer	0.00107	0.00938	CcSEcCtD
Isoprenaline—Palpitations—Ifosfamide—testicular cancer	0.00107	0.00937	CcSEcCtD
Isoprenaline—Convulsion—Ifosfamide—testicular cancer	0.00105	0.00918	CcSEcCtD
Isoprenaline—Hypertension—Ifosfamide—testicular cancer	0.00105	0.00915	CcSEcCtD
Isoprenaline—Dyspnoea—Bleomycin—testicular cancer	0.00103	0.00902	CcSEcCtD
Isoprenaline—Flushing—Etoposide—testicular cancer	0.00102	0.00892	CcSEcCtD
Isoprenaline—Pulmonary oedema—Doxorubicin—testicular cancer	0.00101	0.00884	CcSEcCtD
Isoprenaline—Vision blurred—Cisplatin—testicular cancer	0.000986	0.00861	CcSEcCtD
Isoprenaline—Asthenia—Vinblastine—testicular cancer	0.000985	0.0086	CcSEcCtD
Isoprenaline—Tremor—Cisplatin—testicular cancer	0.00098	0.00856	CcSEcCtD
Isoprenaline—Hyperhidrosis—Ifosfamide—testicular cancer	0.000958	0.00836	CcSEcCtD
Isoprenaline—PIK3R1—Signaling by ERBB4—FGFR3—testicular cancer	0.000954	0.00147	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by EGFR—KIT—testicular cancer	0.000948	0.00146	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Breast Cancer Pathway—STK11—testicular cancer	0.000948	0.00146	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by FGFR in disease—KIT—testicular cancer	0.000942	0.00145	CbGpPWpGaD
Isoprenaline—ADRBK1—DAP12 interactions—KIT—testicular cancer	0.000942	0.00145	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by NGF—KITLG—testicular cancer	0.000941	0.00145	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by EGFR in Cancer—KIT—testicular cancer	0.00094	0.00145	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by PDGF—KIT—testicular cancer	0.000935	0.00144	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by EGFR—KIT—testicular cancer	0.000934	0.00144	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—INSL3—testicular cancer	0.000932	0.00144	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by SCF-KIT—KIT—testicular cancer	0.00093	0.00143	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by SCF-KIT—KITLG—testicular cancer	0.000926	0.00143	CbGpPWpGaD
Isoprenaline—Hypotension—Ifosfamide—testicular cancer	0.000926	0.00808	CcSEcCtD
Isoprenaline—ADRBK1—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000926	0.00142	CbGpPWpGaD
Isoprenaline—PIK3R2—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000923	0.00142	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by PDGF—KIT—testicular cancer	0.000921	0.00142	CbGpPWpGaD
Isoprenaline—PIK3R1—Downstream signal transduction—FGFR3—testicular cancer	0.000911	0.0014	CbGpPWpGaD
Isoprenaline—ADRBK1—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000909	0.0014	CbGpPWpGaD
Isoprenaline—Dizziness—Vinblastine—testicular cancer	0.000908	0.00792	CcSEcCtD
Isoprenaline—Convulsion—Cisplatin—testicular cancer	0.000907	0.00792	CcSEcCtD
Isoprenaline—PIK3R1—Signaling by FGFR—FGFR3—testicular cancer	0.000906	0.00139	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—BCL10—testicular cancer	0.000903	0.00139	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by ERBB2—FGFR3—testicular cancer	0.000902	0.00139	CbGpPWpGaD
Isoprenaline—PIK3R1—DAP12 signaling—FGFR3—testicular cancer	0.000897	0.00138	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by NGF—FGFR3—testicular cancer	0.00089	0.00137	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—BCL10—testicular cancer	0.00089	0.00137	CbGpPWpGaD
Isoprenaline—Nausea—Chlorambucil—testicular cancer	0.00089	0.00777	CcSEcCtD
Isoprenaline—PIK3R1—Downstream signaling of activated FGFR—KIT—testicular cancer	0.00089	0.00137	CbGpPWpGaD
Isoprenaline—MAPK1—Downstream signaling of activated FGFR—KITLG—testicular cancer	0.000886	0.00136	CbGpPWpGaD
Isoprenaline—PIK3R2—B Cell Activation—KIT—testicular cancer	0.000885	0.00136	CbGpPWpGaD
Isoprenaline—PIK3R1—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—testicular cancer	0.000884	0.00136	CbGpPWpGaD
Isoprenaline—Dyspnoea—Ifosfamide—testicular cancer	0.000883	0.00771	CcSEcCtD
Isoprenaline—PIK3R1—Signaling by ERBB4—KIT—testicular cancer	0.000875	0.00135	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—INSL3—testicular cancer	0.000874	0.00134	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by ERBB4—KITLG—testicular cancer	0.000872	0.00134	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—BCL10—testicular cancer	0.000867	0.00133	CbGpPWpGaD
Isoprenaline—Vertigo—Etoposide—testicular cancer	0.000861	0.00752	CcSEcCtD
Isoprenaline—Headache—Vinblastine—testicular cancer	0.00086	0.00751	CcSEcCtD
Isoprenaline—Cardiac arrest—Epirubicin—testicular cancer	0.000849	0.00741	CcSEcCtD
Isoprenaline—PIK3R2—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.000847	0.0013	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by FGFR in disease—FGFR3—testicular cancer	0.000844	0.0013	CbGpPWpGaD
Isoprenaline—PIK3R1—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000844	0.0013	CbGpPWpGaD
Isoprenaline—PIK3R1—DAP12 interactions—FGFR3—testicular cancer	0.000844	0.0013	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by EGFR—FGFR3—testicular cancer	0.000837	0.00129	CbGpPWpGaD
Isoprenaline—PIK3R1—Downstream signal transduction—KIT—testicular cancer	0.000836	0.00129	CbGpPWpGaD
Isoprenaline—ADRBK1—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.000835	0.00128	CbGpPWpGaD
Isoprenaline—Tachycardia—Cisplatin—testicular cancer	0.000834	0.00728	CcSEcCtD
Isoprenaline—MAPK1—Downstream signal transduction—KITLG—testicular cancer	0.000833	0.00128	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by FGFR—KIT—testicular cancer	0.000832	0.00128	CbGpPWpGaD
Isoprenaline—Asthenia—Bleomycin—testicular cancer	0.000832	0.00726	CcSEcCtD
Isoprenaline—Convulsion—Etoposide—testicular cancer	0.000831	0.00725	CcSEcCtD
Isoprenaline—PIK3R1—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000829	0.00128	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by FGFR—KITLG—testicular cancer	0.000829	0.00128	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by ERBB2—KIT—testicular cancer	0.000828	0.00127	CbGpPWpGaD
Isoprenaline—Hypertension—Etoposide—testicular cancer	0.000828	0.00723	CcSEcCtD
Isoprenaline—Hyperhidrosis—Cisplatin—testicular cancer	0.000826	0.00721	CcSEcCtD
Isoprenaline—PIK3R1—Signaling by PDGF—FGFR3—testicular cancer	0.000826	0.00127	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by ERBB2—KITLG—testicular cancer	0.000825	0.00127	CbGpPWpGaD
Isoprenaline—PIK3R1—DAP12 signaling—KIT—testicular cancer	0.000824	0.00127	CbGpPWpGaD
Isoprenaline—MAPK1—DAP12 signaling—KITLG—testicular cancer	0.000821	0.00126	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000819	0.00126	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by NGF—KIT—testicular cancer	0.000817	0.00126	CbGpPWpGaD
Isoprenaline—Nausea—Vinblastine—testicular cancer	0.000815	0.00712	CcSEcCtD
Isoprenaline—PIK3R1—Downstream signaling events of B Cell Receptor (BCR)—KIT—testicular cancer	0.000812	0.00125	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular Senescence—H2AFZ—testicular cancer	0.000807	0.00124	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by Insulin receptor—FGFR3—testicular cancer	0.000805	0.00124	CbGpPWpGaD
Isoprenaline—MAPK1—M Phase—MAD1L1—testicular cancer	0.0008	0.00123	CbGpPWpGaD
Isoprenaline—Hypotension—Cisplatin—testicular cancer	0.000798	0.00697	CcSEcCtD
Isoprenaline—Cardiac arrest—Doxorubicin—testicular cancer	0.000785	0.00686	CcSEcCtD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000785	0.00121	CbGpPWpGaD
Isoprenaline—PIK3R1—B Cell Activation—FGFR3—testicular cancer	0.000781	0.0012	CbGpPWpGaD
Isoprenaline—Asthenia—Dactinomycin—testicular cancer	0.000776	0.00677	CcSEcCtD
Isoprenaline—PIK3R1—DAP12 interactions—KIT—testicular cancer	0.000775	0.00119	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by FGFR in disease—KIT—testicular cancer	0.000775	0.00119	CbGpPWpGaD
Isoprenaline—PIK3R1—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000775	0.00119	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by NGF—KITLG—testicular cancer	0.000774	0.00119	CbGpPWpGaD
Isoprenaline—MAPK1—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.000772	0.00119	CbGpPWpGaD
Isoprenaline—MAPK1—DAP12 interactions—KITLG—testicular cancer	0.000772	0.00119	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by FGFR in disease—KITLG—testicular cancer	0.000772	0.00119	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by EGFR—KIT—testicular cancer	0.000768	0.00118	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by EGFR—KITLG—testicular cancer	0.000765	0.00118	CbGpPWpGaD
Isoprenaline—Tachycardia—Etoposide—testicular cancer	0.000764	0.00667	CcSEcCtD
Isoprenaline—Dyspnoea—Cisplatin—testicular cancer	0.000761	0.00665	CcSEcCtD
Isoprenaline—PIK3R1—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000761	0.00117	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.000758	0.00117	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by PDGF—KIT—testicular cancer	0.000758	0.00117	CbGpPWpGaD
Isoprenaline—Hyperhidrosis—Etoposide—testicular cancer	0.000756	0.0066	CcSEcCtD
Isoprenaline—MAPK1—Signaling by PDGF—KITLG—testicular cancer	0.000755	0.00116	CbGpPWpGaD
Isoprenaline—Angina pectoris—Epirubicin—testicular cancer	0.000751	0.00656	CcSEcCtD
Isoprenaline—PIK3R1—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000748	0.00115	CbGpPWpGaD
Isoprenaline—MAPK1—Mitotic M-M/G1 phases—MAD1L1—testicular cancer	0.000733	0.00113	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—BCL10—testicular cancer	0.000732	0.00113	CbGpPWpGaD
Isoprenaline—Hypotension—Etoposide—testicular cancer	0.000731	0.00638	CcSEcCtD
Isoprenaline—PIK3R1—B Cell Activation—KIT—testicular cancer	0.000717	0.0011	CbGpPWpGaD
Isoprenaline—Asthenia—Ifosfamide—testicular cancer	0.000711	0.00621	CcSEcCtD
Isoprenaline—PIK3R2—Signaling by NGF—FGFR3—testicular cancer	0.00071	0.00109	CbGpPWpGaD
Isoprenaline—Sweating—Methotrexate—testicular cancer	0.000705	0.00615	CcSEcCtD
Isoprenaline—PIK3R1—Adaptive Immune System—BCL10—testicular cancer	0.000703	0.00108	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by NGF—FGFR3—testicular cancer	0.000699	0.00108	CbGpPWpGaD
Isoprenaline—Dyspnoea—Etoposide—testicular cancer	0.000698	0.00609	CcSEcCtD
Isoprenaline—PIK3R2—Signaling Pathways—INSL3—testicular cancer	0.000697	0.00107	CbGpPWpGaD
Isoprenaline—Angina pectoris—Doxorubicin—testicular cancer	0.000695	0.00607	CcSEcCtD
Isoprenaline—Nausea—Bleomycin—testicular cancer	0.000689	0.00601	CcSEcCtD
Isoprenaline—MAPK1—Signaling by SCF-KIT—FGFR3—testicular cancer	0.000688	0.00106	CbGpPWpGaD
Isoprenaline—PIK3R1—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.000686	0.00106	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—INSL3—testicular cancer	0.000686	0.00106	CbGpPWpGaD
Isoprenaline—MAPK1—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000684	0.00105	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—KITLG—testicular cancer	0.000683	0.00105	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000664	0.00102	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—BCL10—testicular cancer	0.00066	0.00102	CbGpPWpGaD
Isoprenaline—Sweating—Epirubicin—testicular cancer	0.000659	0.00576	CcSEcCtD
Isoprenaline—MAPK1—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	0.000659	0.00101	CbGpPWpGaD
Isoprenaline—MAPK1—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.000659	0.00101	CbGpPWpGaD
Isoprenaline—PIK3R3—Adaptive Immune System—KITLG—testicular cancer	0.000656	0.00101	CbGpPWpGaD
Isoprenaline—Dizziness—Ifosfamide—testicular cancer	0.000655	0.00572	CcSEcCtD
Isoprenaline—CYP1A1—Biological oxidations—HPGDS—testicular cancer	0.000652	0.001	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by NGF—KIT—testicular cancer	0.000652	0.001	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—INSL3—testicular cancer	0.000649	0.000999	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by ERBB4—FGFR3—testicular cancer	0.000648	0.000998	CbGpPWpGaD
Isoprenaline—Nausea—Dactinomycin—testicular cancer	0.000642	0.00561	CcSEcCtD
Isoprenaline—ADRBK1—Signaling by NGF—KIT—testicular cancer	0.000642	0.000988	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by SCF-KIT—KIT—testicular cancer	0.000632	0.000973	CbGpPWpGaD
Isoprenaline—MAPK1—Downstream signal transduction—FGFR3—testicular cancer	0.000619	0.000953	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by FGFR—FGFR3—testicular cancer	0.000616	0.000948	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by ERBB2—FGFR3—testicular cancer	0.000613	0.000943	CbGpPWpGaD
Isoprenaline—Asthenia—Cisplatin—testicular cancer	0.000613	0.00535	CcSEcCtD
Isoprenaline—Sweating—Doxorubicin—testicular cancer	0.00061	0.00533	CcSEcCtD
Isoprenaline—MAPK1—DAP12 signaling—FGFR3—testicular cancer	0.00061	0.000939	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—H2AFZ—testicular cancer	0.00061	0.000938	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—INSL3—testicular cancer	0.000609	0.000938	CbGpPWpGaD
Isoprenaline—MAPK1—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000605	0.000931	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—INSL3—testicular cancer	0.000596	0.000918	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by ERBB4—KIT—testicular cancer	0.000595	0.000916	CbGpPWpGaD
Isoprenaline—Nausea—Ifosfamide—testicular cancer	0.000588	0.00514	CcSEcCtD
Isoprenaline—PIK3R1—Signaling by NGF—FGFR3—testicular cancer	0.000575	0.000885	CbGpPWpGaD
Isoprenaline—MAPK1—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000574	0.000883	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by FGFR in disease—FGFR3—testicular cancer	0.000574	0.000883	CbGpPWpGaD
Isoprenaline—MAPK1—DAP12 interactions—FGFR3—testicular cancer	0.000574	0.000883	CbGpPWpGaD
Isoprenaline—Flushing—Epirubicin—testicular cancer	0.000573	0.005	CcSEcCtD
Isoprenaline—MAPK1—Signaling by EGFR—FGFR3—testicular cancer	0.000569	0.000875	CbGpPWpGaD
Isoprenaline—MAPK1—Downstream signal transduction—KIT—testicular cancer	0.000568	0.000875	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by FGFR—KIT—testicular cancer	0.000566	0.00087	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—INSL3—testicular cancer	0.000564	0.000869	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000564	0.000867	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by ERBB2—KIT—testicular cancer	0.000563	0.000866	CbGpPWpGaD
Isoprenaline—Asthenia—Etoposide—testicular cancer	0.000561	0.0049	CcSEcCtD
Isoprenaline—MAPK1—Signaling by PDGF—FGFR3—testicular cancer	0.000561	0.000864	CbGpPWpGaD
Isoprenaline—MAPK1—DAP12 signaling—KIT—testicular cancer	0.00056	0.000862	CbGpPWpGaD
Isoprenaline—MAPK1—M Phase—H2AFZ—testicular cancer	0.000558	0.000858	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—INSL3—testicular cancer	0.000553	0.000852	CbGpPWpGaD
Isoprenaline—Arrhythmia—Epirubicin—testicular cancer	0.000552	0.00482	CcSEcCtD
Isoprenaline—ADRB3—Signaling Pathways—INSL3—testicular cancer	0.000551	0.000848	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle, Mitotic—MAD1L1—testicular cancer	0.000548	0.000844	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—KITLG—testicular cancer	0.000545	0.000838	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—INSL3—testicular cancer	0.000541	0.000833	CbGpPWpGaD
Isoprenaline—Vision blurred—Methotrexate—testicular cancer	0.000541	0.00473	CcSEcCtD
Isoprenaline—ADRBK1—Innate Immune System—KITLG—testicular cancer	0.000537	0.000826	CbGpPWpGaD
Isoprenaline—Flushing—Doxorubicin—testicular cancer	0.00053	0.00463	CcSEcCtD
Isoprenaline—PIK3R1—Signaling by NGF—KIT—testicular cancer	0.000528	0.000813	CbGpPWpGaD
Isoprenaline—Tension—Epirubicin—testicular cancer	0.000527	0.0046	CcSEcCtD
Isoprenaline—MAPK1—Signaling by FGFR in disease—KIT—testicular cancer	0.000527	0.000811	CbGpPWpGaD
Isoprenaline—MAPK1—DAP12 interactions—KIT—testicular cancer	0.000527	0.000811	CbGpPWpGaD
Isoprenaline—MAPK1—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000527	0.000811	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—BCL10—testicular cancer	0.000526	0.00081	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—KITLG—testicular cancer	0.000526	0.000809	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—KITLG—testicular cancer	0.000523	0.000805	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by EGFR—KIT—testicular cancer	0.000522	0.000804	CbGpPWpGaD
Isoprenaline—Nervousness—Epirubicin—testicular cancer	0.000522	0.00456	CcSEcCtD
Isoprenaline—ADRBK1—Immune System—BCL10—testicular cancer	0.000518	0.000798	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000518	0.000796	CbGpPWpGaD
Isoprenaline—Dizziness—Etoposide—testicular cancer	0.000517	0.00452	CcSEcCtD
Isoprenaline—Vertigo—Methotrexate—testicular cancer	0.000516	0.0045	CcSEcCtD
Isoprenaline—MAPK1—Signaling by PDGF—KIT—testicular cancer	0.000515	0.000793	CbGpPWpGaD
Isoprenaline—MAPK1—Mitotic M-M/G1 phases—H2AFZ—testicular cancer	0.000511	0.000787	CbGpPWpGaD
Isoprenaline—Arrhythmia—Doxorubicin—testicular cancer	0.00051	0.00446	CcSEcCtD
Isoprenaline—MAPK1—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000508	0.000782	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—FGFR3—testicular cancer	0.000508	0.000782	CbGpPWpGaD
Isoprenaline—Nausea—Cisplatin—testicular cancer	0.000507	0.00443	CcSEcCtD
Isoprenaline—Vision blurred—Epirubicin—testicular cancer	0.000506	0.00442	CcSEcCtD
Isoprenaline—Convulsion—Methotrexate—testicular cancer	0.000498	0.00434	CcSEcCtD
Isoprenaline—MAPK1—Innate Immune System—BCL10—testicular cancer	0.000497	0.000766	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—MAD1L1—testicular cancer	0.00049	0.000755	CbGpPWpGaD
Isoprenaline—Headache—Etoposide—testicular cancer	0.00049	0.00428	CcSEcCtD
Isoprenaline—Tension—Doxorubicin—testicular cancer	0.000488	0.00426	CcSEcCtD
Isoprenaline—PIK3R3—Adaptive Immune System—FGFR3—testicular cancer	0.000488	0.000751	CbGpPWpGaD
Isoprenaline—Nervousness—Doxorubicin—testicular cancer	0.000483	0.00422	CcSEcCtD
Isoprenaline—Vertigo—Epirubicin—testicular cancer	0.000483	0.00422	CcSEcCtD
Isoprenaline—Palpitations—Epirubicin—testicular cancer	0.000475	0.00415	CcSEcCtD
Isoprenaline—Vision blurred—Doxorubicin—testicular cancer	0.000469	0.00409	CcSEcCtD
Isoprenaline—MAPK1—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.000467	0.000718	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—KIT—testicular cancer	0.000466	0.000718	CbGpPWpGaD
Isoprenaline—Convulsion—Epirubicin—testicular cancer	0.000466	0.00407	CcSEcCtD
Isoprenaline—Nausea—Etoposide—testicular cancer	0.000465	0.00406	CcSEcCtD
Isoprenaline—Hypertension—Epirubicin—testicular cancer	0.000464	0.00405	CcSEcCtD
Isoprenaline—PIK3R3—Metabolism—HPGDS—testicular cancer	0.000458	0.000704	CbGpPWpGaD
Isoprenaline—Hyperhidrosis—Methotrexate—testicular cancer	0.000453	0.00396	CcSEcCtD
Isoprenaline—PIK3R3—Adaptive Immune System—KIT—testicular cancer	0.000448	0.000689	CbGpPWpGaD
Isoprenaline—Vertigo—Doxorubicin—testicular cancer	0.000447	0.0039	CcSEcCtD
Isoprenaline—PIK3R1—Innate Immune System—KITLG—testicular cancer	0.000441	0.000679	CbGpPWpGaD
Isoprenaline—Palpitations—Doxorubicin—testicular cancer	0.000439	0.00384	CcSEcCtD
Isoprenaline—Hypotension—Methotrexate—testicular cancer	0.000438	0.00382	CcSEcCtD
Isoprenaline—Convulsion—Doxorubicin—testicular cancer	0.000431	0.00376	CcSEcCtD
Isoprenaline—Hypertension—Doxorubicin—testicular cancer	0.000429	0.00375	CcSEcCtD
Isoprenaline—Tachycardia—Epirubicin—testicular cancer	0.000428	0.00374	CcSEcCtD
Isoprenaline—PIK3R1—Immune System—BCL10—testicular cancer	0.000426	0.000656	CbGpPWpGaD
Isoprenaline—Hyperhidrosis—Epirubicin—testicular cancer	0.000424	0.0037	CcSEcCtD
Isoprenaline—Insomnia—Methotrexate—testicular cancer	0.000424	0.0037	CcSEcCtD
Isoprenaline—PIK3R1—Adaptive Immune System—KITLG—testicular cancer	0.000424	0.000652	CbGpPWpGaD
Isoprenaline—Dyspnoea—Methotrexate—testicular cancer	0.000418	0.00365	CcSEcCtD
Isoprenaline—Hypotension—Epirubicin—testicular cancer	0.00041	0.00358	CcSEcCtD
Isoprenaline—PIK3R2—Innate Immune System—FGFR3—testicular cancer	0.000405	0.000623	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—H2AFZ—testicular cancer	0.000399	0.000615	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—FGFR3—testicular cancer	0.000399	0.000614	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—KITLG—testicular cancer	0.000398	0.000613	CbGpPWpGaD
Isoprenaline—Insomnia—Epirubicin—testicular cancer	0.000397	0.00346	CcSEcCtD
Isoprenaline—Tachycardia—Doxorubicin—testicular cancer	0.000396	0.00346	CcSEcCtD
Isoprenaline—Hyperhidrosis—Doxorubicin—testicular cancer	0.000392	0.00343	CcSEcCtD
Isoprenaline—Dyspnoea—Epirubicin—testicular cancer	0.000391	0.00341	CcSEcCtD
Isoprenaline—MAPK1—Signaling by NGF—FGFR3—testicular cancer	0.000391	0.000602	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—FGFR3—testicular cancer	0.000389	0.000598	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—INSL3—testicular cancer	0.000384	0.00059	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle, Mitotic—H2AFZ—testicular cancer	0.000382	0.000588	CbGpPWpGaD
Isoprenaline—Hypotension—Doxorubicin—testicular cancer	0.000379	0.00331	CcSEcCtD
Isoprenaline—PIK3R2—Innate Immune System—KIT—testicular cancer	0.000372	0.000572	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—KITLG—testicular cancer	0.000367	0.000566	CbGpPWpGaD
Isoprenaline—Insomnia—Doxorubicin—testicular cancer	0.000367	0.0032	CcSEcCtD
Isoprenaline—ADRBK1—Innate Immune System—KIT—testicular cancer	0.000366	0.000563	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—HPGDS—testicular cancer	0.000365	0.000562	CbGpPWpGaD
Isoprenaline—Dyspnoea—Doxorubicin—testicular cancer	0.000362	0.00316	CcSEcCtD
Isoprenaline—MAPK1—Signaling by NGF—KIT—testicular cancer	0.000359	0.000552	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—KIT—testicular cancer	0.000357	0.000549	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—H2AFZ—testicular cancer	0.000342	0.000526	CbGpPWpGaD
Isoprenaline—Asthenia—Methotrexate—testicular cancer	0.000336	0.00294	CcSEcCtD
Isoprenaline—PIK3R3—Metabolism—STK11—testicular cancer	0.000333	0.000512	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—FGFR3—testicular cancer	0.000328	0.000505	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—INSL3—testicular cancer	0.000327	0.000503	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—INSL3—testicular cancer	0.00032	0.000492	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—H2AFZ—testicular cancer	0.000318	0.00049	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—KITLG—testicular cancer	0.000317	0.000488	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—FGFR3—testicular cancer	0.000315	0.000485	CbGpPWpGaD
Isoprenaline—Asthenia—Epirubicin—testicular cancer	0.000315	0.00275	CcSEcCtD
Isoprenaline—ADRBK1—Disease—H2AFZ—testicular cancer	0.000314	0.000483	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—KITLG—testicular cancer	0.000312	0.000481	CbGpPWpGaD
Isoprenaline—Dizziness—Methotrexate—testicular cancer	0.00031	0.00271	CcSEcCtD
Isoprenaline—PIK3R1—Innate Immune System—KIT—testicular cancer	0.000301	0.000463	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—KITLG—testicular cancer	0.0003	0.000462	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—FGFR3—testicular cancer	0.000296	0.000455	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—HPGDS—testicular cancer	0.000296	0.000455	CbGpPWpGaD
Isoprenaline—Headache—Methotrexate—testicular cancer	0.000294	0.00256	CcSEcCtD
Isoprenaline—PIK3R2—Disease—KITLG—testicular cancer	0.000293	0.000451	CbGpPWpGaD
Isoprenaline—Asthenia—Doxorubicin—testicular cancer	0.000291	0.00254	CcSEcCtD
Isoprenaline—Dizziness—Epirubicin—testicular cancer	0.00029	0.00253	CcSEcCtD
Isoprenaline—MAPK1—Immune System—BCL10—testicular cancer	0.00029	0.000446	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—KIT—testicular cancer	0.000289	0.000445	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—KITLG—testicular cancer	0.000289	0.000444	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—MMP2—testicular cancer	0.000288	0.000443	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—H2AFZ—testicular cancer	0.00028	0.00043	CbGpPWpGaD
Isoprenaline—Nausea—Methotrexate—testicular cancer	0.000278	0.00243	CcSEcCtD
Isoprenaline—PIK3R3—Signaling Pathways—STK11—testicular cancer	0.000278	0.000428	CbGpPWpGaD
Isoprenaline—Headache—Epirubicin—testicular cancer	0.000275	0.0024	CcSEcCtD
Isoprenaline—PIK3R3—Disease—FGFR3—testicular cancer	0.000273	0.00042	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—KIT—testicular cancer	0.000272	0.000418	CbGpPWpGaD
Isoprenaline—Dizziness—Doxorubicin—testicular cancer	0.000268	0.00234	CcSEcCtD
Isoprenaline—PIK3R2—Metabolism—STK11—testicular cancer	0.000265	0.000408	CbGpPWpGaD
Isoprenaline—Nausea—Epirubicin—testicular cancer	0.000261	0.00227	CcSEcCtD
Isoprenaline—PIK3R1—Disease—H2AFZ—testicular cancer	0.000258	0.000397	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—KITLG—testicular cancer	0.000257	0.000396	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—KITLG—testicular cancer	0.000257	0.000396	CbGpPWpGaD
Isoprenaline—Headache—Doxorubicin—testicular cancer	0.000254	0.00222	CcSEcCtD
Isoprenaline—PIK3R3—Disease—KIT—testicular cancer	0.000251	0.000386	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.00025	0.000385	CbGpPWpGaD
Isoprenaline—Nausea—Doxorubicin—testicular cancer	0.000241	0.0021	CcSEcCtD
Isoprenaline—PIK3R1—Disease—KITLG—testicular cancer	0.000237	0.000365	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—FGFR3—testicular cancer	0.000236	0.000363	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—FGFR3—testicular cancer	0.000232	0.000357	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—H2AFZ—testicular cancer	0.000223	0.000343	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—FGFR3—testicular cancer	0.000223	0.000343	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—STK11—testicular cancer	0.000222	0.000341	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—H2AFZ—testicular cancer	0.00022	0.000338	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—STK11—testicular cancer	0.000218	0.000336	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—FGFR3—testicular cancer	0.000218	0.000335	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—KIT—testicular cancer	0.000216	0.000333	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—STK11—testicular cancer	0.000215	0.000331	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—FGFR3—testicular cancer	0.000214	0.00033	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—KIT—testicular cancer	0.000213	0.000328	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—MMP2—testicular cancer	0.000205	0.000316	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—KITLG—testicular cancer	0.000205	0.000316	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—KIT—testicular cancer	0.000205	0.000315	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—KITLG—testicular cancer	0.000202	0.000311	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—KIT—testicular cancer	0.0002	0.000308	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—KIT—testicular cancer	0.000197	0.000303	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—FGFR3—testicular cancer	0.000191	0.000294	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—FGFR3—testicular cancer	0.000191	0.000294	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—H2AFZ—testicular cancer	0.000181	0.000278	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—STK11—testicular cancer	0.00018	0.000276	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—FGFR3—testicular cancer	0.000176	0.000271	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—H2AFZ—testicular cancer	0.000176	0.000271	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—KIT—testicular cancer	0.000176	0.00027	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—KIT—testicular cancer	0.000175	0.00027	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—H2AFZ—testicular cancer	0.000175	0.00027	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—STK11—testicular cancer	0.000175	0.00027	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—KITLG—testicular cancer	0.000175	0.000269	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—KITLG—testicular cancer	0.000166	0.000256	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—KITLG—testicular cancer	0.000162	0.00025	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—KIT—testicular cancer	0.000162	0.000249	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—KITLG—testicular cancer	0.000161	0.000248	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—FGFR3—testicular cancer	0.000152	0.000235	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—FGFR3—testicular cancer	0.00015	0.000231	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—KIT—testicular cancer	0.00014	0.000215	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—KIT—testicular cancer	0.000138	0.000212	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—FGFR3—testicular cancer	0.00013	0.0002	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—FGFR3—testicular cancer	0.000124	0.00019	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—H2AFZ—testicular cancer	0.000123	0.000189	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—STK11—testicular cancer	0.000122	0.000188	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—FGFR3—testicular cancer	0.000121	0.000186	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—FGFR3—testicular cancer	0.00012	0.000185	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—KIT—testicular cancer	0.000119	0.000183	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—KIT—testicular cancer	0.000113	0.000175	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—KITLG—testicular cancer	0.000113	0.000174	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—HPGDS—testicular cancer	0.000111	0.000172	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—KIT—testicular cancer	0.000111	0.00017	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—KIT—testicular cancer	0.00011	0.000169	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—H2AFZ—testicular cancer	0.000105	0.000161	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—STK11—testicular cancer	0.000104	0.00016	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—H2AFZ—testicular cancer	0.000102	0.000158	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—STK11—testicular cancer	0.000102	0.000157	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—KITLG—testicular cancer	9.63e-05	0.000148	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—KITLG—testicular cancer	9.42e-05	0.000145	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—FGFR3—testicular cancer	8.4e-05	0.000129	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—STK11—testicular cancer	8.1e-05	0.000125	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—KIT—testicular cancer	7.71e-05	0.000119	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—FGFR3—testicular cancer	7.16e-05	0.00011	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—FGFR3—testicular cancer	7e-05	0.000108	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—KIT—testicular cancer	6.57e-05	0.000101	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—KIT—testicular cancer	6.43e-05	9.89e-05	CbGpPWpGaD
